Skip to search formSkip to main contentSkip to account menu

Almorexant

Known as: ((2R)-2-((1S)-6,7-dimethoxy-1-(2-(4-trifluoromethylphenyl)-ethyl)-3,4-dihydro-1H-isoquinolin-2-yl)-N-methyl-2-phenylacetamide), (2R)-2-((1S)-6,7-Dimethoxy-1-(2-(4-(Trifluoromethyl)Phenyl)Ethyl)-3,4-Dihydroisoquinolin-2(1H)-Yl)-N-Methyl-2-Phenylacetamide 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

ACT-078573

Broader (2)

AcetamidesIsoquinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Dual orexin receptor antagonist, almorexant, in elderly patients with primary insomnia: a randomized, controlled study.
OBJECTIVE Sleep laboratory study to determine the dose-related efficacy and safety of almorexant in elderly patients with primary… 
2012
2012
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat
The rat fear-potentiated startle (FPS) paradigm is a translational model of conditioned fear involving central amygdala pathways… 
2009
2009
Molecule of the month. Almorexant.